CEPI and Samsung Biologics have partnered in an outbreak-ready vaccine manufacturing partnership to enhance the preparedness ...

Despite posting strong results in the final quarter of 2025, MSD (Merck & Co) has cut its 2026 guidance more than analysts ...

SanegeneBio has entered into a $1.5bn global licensing agreement with Genentech, part of the Roche Group, for one of its RNAi ...

Recent reports of Nipah virus (NiV) infections in West Bengal, India, have reignited global concern, prompting public health ...

As FY25 results reveal a mixed year for Pfizer, the company is looking to turn its fortunes around with newly acquired Metsera obesity assets.

Sino Biological US, Inc., a global leader in recombinant proteins, antibodies, and CRO services, will be featured on Inside ...

Aquestive has received a CRL from the FDA regarding its NDA for Anaphylm, which aims to treat type I allergic reactions in patients weighing 30kg or more.

Historically a steel production hub, Lehigh Valley will now help manufacture Lilly’s weight loss drug hopeful retatrutide.

Kyowa Kirin will now file for rocatinlimab’s US approval in atopic dermatitis (AD), which was once Amgen’s most late-stage pipeline candidate.

The California Institute for Regenerative Medicine has approved the RAPID funding programme, setting aside $100m over two ...

AstraZeneca's investment coincides with China’s burgeoning presence in the pharmaceutical industry, driven by an uptick in ...

Repertoire Immune Medicines has collaborated with Eli Lilly for the development of tolerising therapies to treat several ...